Noka Yogahutama, Muhammad Isa Fuad Affan, Alan Primi Ladese, Nicholas Abraham
{"title":"Comparison on Surgical Outcomes of Mini-Versus Standard-Percutaneous Nephrolithotomy in Staghorn Calculi: A Systematic Review and Meta-Analysis.","authors":"Noka Yogahutama, Muhammad Isa Fuad Affan, Alan Primi Ladese, Nicholas Abraham","doi":"10.5152/tud.2025.24125","DOIUrl":null,"url":null,"abstract":"<p><p>Percutaneous Nephrolithotomy (PCNL) has become the standard for managing staghorn calculi. Smaller access sheath Mini-PCNL (M-PCNL) has been known for its advantages in surgical outcomes compared with Standard-PCNL (S-PCNL) in various settings. We conducted this systematic review to compare surgical outcomes and postoperative complications of M-PCNL vs. S-PCNL in staghorn calculi treatment. A systematic search of the literature was performed on PubMed, Cochrane Library, ProQuest, Scopus, ClinicalTrials.gov, and Google Scholar according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA Statement). Five randomized controlled trial (RCT) and 5 cohort studies were included. Risk of bias assessment was evaluated using Cochrane risk of bias (RoB) 2 and Cochrane RoB in Nonrandomized Studies - of Interventions (ROBINS-I). Ten studies involving 1733 staghorn calculi patients met the inclusion criteria. The stone-free rate (SFR) was comparable (odds ratio (OR) 1.13, 95% CI: 0.90-1.43, P = .28) compared to S-PCNL. Pooled analysis showed that M-PCNL resulted in a significantly lower shorter operative time (mean differences (MD) 14.06, 95% CI: 6.09-22.03, P < .001), lower blood transfusion (OR 0.46, 95% CI: 0.29-0.72, P < .001), and lower hemoglobin drop (MD !0.37, 95% CI: !0.72 to !0.03, P = .03) compared to S-PCNL. This meta-analysis suggests that while M-PCNL has comparable SFR to S-PCNL, it offers benefits in terms of shorter operative time, reduced blood transfusion needs, and less hemoglobin drop.</p>","PeriodicalId":101337,"journal":{"name":"Urology research & practice","volume":"50 5","pages":"281-290"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11923600/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology research & practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/tud.2025.24125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Percutaneous Nephrolithotomy (PCNL) has become the standard for managing staghorn calculi. Smaller access sheath Mini-PCNL (M-PCNL) has been known for its advantages in surgical outcomes compared with Standard-PCNL (S-PCNL) in various settings. We conducted this systematic review to compare surgical outcomes and postoperative complications of M-PCNL vs. S-PCNL in staghorn calculi treatment. A systematic search of the literature was performed on PubMed, Cochrane Library, ProQuest, Scopus, ClinicalTrials.gov, and Google Scholar according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA Statement). Five randomized controlled trial (RCT) and 5 cohort studies were included. Risk of bias assessment was evaluated using Cochrane risk of bias (RoB) 2 and Cochrane RoB in Nonrandomized Studies - of Interventions (ROBINS-I). Ten studies involving 1733 staghorn calculi patients met the inclusion criteria. The stone-free rate (SFR) was comparable (odds ratio (OR) 1.13, 95% CI: 0.90-1.43, P = .28) compared to S-PCNL. Pooled analysis showed that M-PCNL resulted in a significantly lower shorter operative time (mean differences (MD) 14.06, 95% CI: 6.09-22.03, P < .001), lower blood transfusion (OR 0.46, 95% CI: 0.29-0.72, P < .001), and lower hemoglobin drop (MD !0.37, 95% CI: !0.72 to !0.03, P = .03) compared to S-PCNL. This meta-analysis suggests that while M-PCNL has comparable SFR to S-PCNL, it offers benefits in terms of shorter operative time, reduced blood transfusion needs, and less hemoglobin drop.
经皮肾镜取石术(PCNL)已成为治疗鹿角型结石的标准方法。在各种情况下,与标准pcnl (S-PCNL)相比,更小的导管鞘Mini-PCNL (M-PCNL)以其在手术结果方面的优势而闻名。我们对M-PCNL与S-PCNL治疗鹿角型结石的手术效果和术后并发症进行了系统评价。系统检索PubMed、Cochrane Library、ProQuest、Scopus、ClinicalTrials.gov和谷歌Scholar等网站的文献,按照系统评价和meta分析声明的首选报告项目(PRISMA Statement)进行检索。纳入5项随机对照试验(RCT)和5项队列研究。采用Cochrane Risk of bias (RoB) 2和Cochrane RoB in non - random Studies of Interventions (ROBINS-I)评估偏倚风险。10项研究纳入1733例鹿角形结石患者,符合纳入标准。与S-PCNL相比,无结石率(SFR)相当(优势比(OR) 1.13, 95% CI: 0.90-1.43, P = 0.28)。综合分析显示,与S-PCNL相比,M-PCNL缩短手术时间(平均差异(MD) 14.06, 95% CI: 6.09-22.03, P < 0.001),减少输血(OR 0.46, 95% CI: 0.29-0.72, P < 0.001),降低血红蛋白下降(MD 0.37, 95% CI: 0.72 ~ 0.03, P = 0.03)。这项荟萃分析表明,虽然M-PCNL的SFR与S-PCNL相当,但它在缩短手术时间、减少输血需求和减少血红蛋白下降方面具有优势。